关于感染疫苗接种后自身免疫性疾病患者的文献综述。
A literature review on the patients with autoimmune diseases following vaccination against infections.
作者信息
Liang Yan, Meng Fan-Ya, Pan Hai-Feng, Ye Dong-Qing
机构信息
a Department of Epidemiology and Biostatistics ; School of Public Health; Anhui Medical University ; Hefei , China.
出版信息
Hum Vaccin Immunother. 2015;11(9):2274-80. doi: 10.1080/21645515.2015.1009337.
Abstract
Due to immune abnormalities and the use of steroids and immunosuppressant treatment, patients with rheumatic diseases are susceptible to infections. Vaccination is one of the most important prevention tools in modern medicine. A discussion on risk-benefit or cost-benefit analysis, and advisory on individual vaccines or vaccination programs falls outside the scope of this review. In particularly, this review summarizes the knowledge about the effectiveness and safety vaccinations in patients with autoimmune inflammatory rheumatic diseases (AIIRD) treated with biologics. Finally, we aim to provide vaccination plans basis for clinical management of rheumatic patients depending upon prevaccination antibody titers, drug treatments and immunological potential.
摘要
由于免疫异常以及使用类固醇和免疫抑制治疗，风湿病患者易发生感染。疫苗接种是现代医学中最重要的预防手段之一。关于风险效益或成本效益分析以及针对个别疫苗或疫苗接种计划的建议不在本综述范围内。特别是，本综述总结了接受生物制剂治疗的自身免疫性炎性风湿病（AIIRD）患者疫苗接种的有效性和安全性方面的知识。最后，我们旨在根据接种前抗体滴度、药物治疗和免疫潜力为风湿病患者的临床管理提供疫苗接种计划依据。
相似文献
1
A literature review on the patients with autoimmune diseases following vaccination against infections.关于感染疫苗接种后自身免疫性疾病患者的文献综述。
Hum Vaccin Immunother. 2015;11(9):2274-80. doi: 10.1080/21645515.2015.1009337.
2
Vaccination of patients with autoimmune inflammatory rheumatic diseases.自身免疫性炎症性风湿病患者的疫苗接种。
Nat Rev Rheumatol. 2015 Mar;11(3):135-45. doi: 10.1038/nrrheum.2014.206. Epub 2014 Dec 9.
3
Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations.成人自身免疫性炎症性风湿病患者疫苗接种的疗效、免疫原性和安全性：2019 年 EULAR 建议更新的系统文献回顾。
RMD Open. 2019 Sep 9;5(2):e001035. doi: 10.1136/rmdopen-2019-001035. eCollection 2019.
4
Vaccination and auto-immune rheumatic diseases: lessons learnt from the 2009 H1N1 influenza virus vaccination campaign.疫苗接种与自身免疫性风湿病：从 2009 年 H1N1 流感病毒疫苗接种活动中获得的经验教训。
Curr Opin Rheumatol. 2013 Mar;25(2):164-70. doi: 10.1097/BOR.0b013e32835d2b7b.
5
2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases.2019 年更新版：欧洲抗风湿病联盟成人自身免疫性炎症性风湿病患者疫苗接种推荐。
Ann Rheum Dis. 2020 Jan;79(1):39-52. doi: 10.1136/annrheumdis-2019-215882. Epub 2019 Aug 14.
6
Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD.成人自身免疫性炎症性风湿病（AIIRD）患者疫苗可预防感染的发病率和患病率：系统文献回顾，为 2019 年 AIIRD 成人患者疫苗接种 EULAR 建议更新提供信息。
RMD Open. 2019 Sep 19;5(2):e001041. doi: 10.1136/rmdopen-2019-001041. eCollection 2019.
7
Immunization of patients with autoimmune inflammatory rheumatic diseases (the EULAR recommendations).自身免疫性炎症性风湿病患者的免疫接种（EULAR 建议）。
Lupus. 2012 Feb;21(2):162-7. doi: 10.1177/0961203311429555.
8
Vaccination of children and adolescents with rheumatic diseases.儿童和青少年风湿病患者的疫苗接种。
Rheumatology (Oxford). 2011 Aug;50(8):1358-65. doi: 10.1093/rheumatology/ker102. Epub 2011 Apr 10.
9
Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases.成人自身免疫性炎症性风湿病患者的疫苗接种：为欧洲抗风湿病联盟成人自身免疫性炎症性风湿病患者疫苗接种的循证推荐而进行的系统文献回顾。
Autoimmun Rev. 2011 Apr;10(6):341-52. doi: 10.1016/j.autrev.2010.12.003. Epub 2010 Dec 20.
10
A practical approach to vaccination of patients with autoimmune inflammatory rheumatic diseases in Australia.澳大利亚自身免疫性炎性风湿疾病患者疫苗接种的实用方法
Intern Med J. 2017 May;47(5):491-500. doi: 10.1111/imj.13371.
引用本文的文献
1
A Lower Level of Post-Vaccinal Antibody Titer against Influenza Virus A H1N1 May Protect Patients with Autoimmune Rheumatic Diseases from Respiratory Viral Infections.接种疫苗后针对甲型流感病毒 H1N1 的抗体滴度降低可能会保护自身免疫性风湿病患者免受呼吸道病毒感染。
Medicina (Kaunas). 2022 Jan 4;58(1):76. doi: 10.3390/medicina58010076.
2
The Eye of the Storm: COVID-19 Vaccination and the Eye.风暴之眼：新冠疫苗接种与眼睛
Ophthalmol Ther. 2022 Feb;11(1):81-100. doi: 10.1007/s40123-021-00415-5. Epub 2021 Dec 16.
3
Ophthalmological Considerations for COVID-19 Vaccination in Patients with Inflammatory Eye Diseases and Autoimmune Disorders.炎症性眼病和自身免疫性疾病患者接种新冠疫苗的眼科考量
Ophthalmol Ther. 2021 Jun;10(2):201-209. doi: 10.1007/s40123-021-00338-1. Epub 2021 Mar 6.
4
IRE1α Implications in Endoplasmic Reticulum Stress-Mediated Development and Pathogenesis of Autoimmune Diseases.IRE1α 在细胞内质网应激介导的自身免疫性疾病发生发展中的作用。
Front Immunol. 2018 Jun 6;9:1289. doi: 10.3389/fimmu.2018.01289. eCollection 2018.
本文引用的文献
1
Tc17 Cells in Immunity and Systemic Autoimmunity.免疫与系统性自身免疫中的Tc17细胞
Int Rev Immunol. 2015;34(4):318-31. doi: 10.3109/08830185.2014.954698. Epub 2014 Sep 26.
2
Pathogen infection as a possible cause for autoimmune hepatitis.病原体感染作为自身免疫性肝炎的一种可能病因。
Int Rev Immunol. 2014 Jul-Aug;33(4):296-313. doi: 10.3109/08830185.2014.921162. Epub 2014 Jun 9.
3
[Recommendations for prevention of community-acquired pneumonia with bacteremia as the leading form of invasive pneumococcal infections in the population of people over 50 years of age and risk groups above 19 years of age].[关于预防社区获得性肺炎的建议，以菌血症作为50岁以上人群及19岁以上风险群体侵袭性肺炎球菌感染的主要形式]
Pol Merkur Lekarski. 2014 Feb;36(212):79-87.
4
SOCS signaling in autoimmune diseases: molecular mechanisms and therapeutic implications.SOCS 信号在自身免疫性疾病中的作用：分子机制及治疗意义。
Eur J Immunol. 2014 May;44(5):1265-75. doi: 10.1002/eji.201344369. Epub 2014 Mar 27.
5
Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis.利妥昔单抗和阿巴西普但不是托珠单抗会损害类风湿关节炎患者对肺炎球菌结合疫苗的抗体应答。
Arthritis Res Ther. 2013 Oct 30;15(5):R171. doi: 10.1186/ar4358.
6
Immune response to influenza vaccine and pneumococcal polysaccharide vaccine under IL-6 signal inhibition therapy with tocilizumab.在使用托珠单抗进行白细胞介素-6信号抑制治疗下，对流感疫苗和肺炎球菌多糖疫苗的免疫反应。
Mod Rheumatol. 2014 May;24(3):511-6. doi: 10.3109/14397595.2013.843743. Epub 2013 Nov 4.
7
Safety and immunogenicity of the quadrivalent HPV vaccine in female Systemic Lupus Erythematosus patients aged 12 to 26 years.12 至 26 岁女性系统性红斑狼疮患者接种四价 HPV 疫苗的安全性和免疫原性。
Pediatr Rheumatol Online J. 2013 Aug 7;11:29. doi: 10.1186/1546-0096-11-29. eCollection 2013.
8
Vaccination and auto-immune rheumatic diseases: lessons learnt from the 2009 H1N1 influenza virus vaccination campaign.疫苗接种与自身免疫性风湿病：从 2009 年 H1N1 流感病毒疫苗接种活动中获得的经验教训。
Curr Opin Rheumatol. 2013 Mar;25(2):164-70. doi: 10.1097/BOR.0b013e32835d2b7b.
9
Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy.肺炎球菌多糖疫苗接种在接受托珠单抗治疗的类风湿关节炎患者中的应用。
Ann Rheum Dis. 2013 Aug;72(8):1362-6. doi: 10.1136/annrheumdis-2012-202658. Epub 2013 Jan 23.
10
Persistence of antibody response 1.5 years after vaccination using 7-valent pneumococcal conjugate vaccine in patients with arthritis treated with different antirheumatic drugs.在使用7价肺炎球菌结合疫苗进行接种后1.5年，接受不同抗风湿药物治疗的关节炎患者体内抗体反应的持久性。
Arthritis Res Ther. 2013 Jan 4;15(1):R1. doi: 10.1186/ar4127.
Zotero 插件